MYRIAD GENETICS INC — Director's Dealing 2014

Feb 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-02-12

Reporting Person: Harrison Robert Gardner (Chief Information Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-12	Common Stock	M	7500.0	$7.82	Acquired	11025	Direct
2014-02-12	Common Stock	S	7500.0	$30.7444	Disposed	3525	Direct
2014-02-12	Common Stock	M	2500.0	$7.82	Acquired	6025	Direct
2014-02-12	Common Stock	S	2500.0	$30.7444	Disposed	3525	Direct
2014-02-12	Common Stock	M	506.0	$6.0	Acquired	4031	Direct
2014-02-12	Common Stock	S	506.0	$30.7444	Disposed	3525	Direct
2014-02-12	Common Stock	S	3201.0	$30.723	Disposed	324	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-12	Non-Qualified Stock Option (right to buy)	$6.0	M	506.0	Disposed	2014-02-19	Common Stock (506)	Direct
2014-02-12	Non-Qualified Stock Option (right to buy)	$7.82	M	7500.0	Disposed	2015-02-17	Common Stock (7500)	Direct
2014-02-12	Non-Qualified Stock Option (right to buy)	$7.82	M	2500.0	Disposed	2015-02-17	Common Stock (2500)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.